Early Rhythm-Control Therapy and High Comorbidity Burden.
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Latest science in atrial fibrillation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Highlights from the Young in atrial fibrillation
ESC 365 is supported by
